keyword
MENU ▼
Read by QxMD icon Read
search

Saccharomyces boulardii

keyword
https://www.readbyqxmd.com/read/28835355/efficacy-of-lactobacillus-reuteri-dsm-17938-for-the-treatment-of-acute-gastroenteritis-in-children-protocol-of-a-randomized-controlled-trial
#1
Henryk Szymański, Hania Szajewska
BACKGROUND: Acute gastroenteritis (AGE) is one of the most common diseases among children. Oral rehydration therapy is the key treatment. However, despite proven efficacy, it remains underused. This is because oral rehydration solution neither reduces the frequency of bowel movements and fluid loss nor shortens the duration of illness. Hence, there is interest in adjunctive treatments. According to the 2014 guidelines developed by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, the use of the following probiotics may be considered in the management of children with AGE in addition to rehydration therapy: Lactobacillus rhamnosus GG (low quality of evidence; strong recommendation) and Saccharomyces boulardii (low quality of evidence; strong recommendation)...
August 23, 2017: JMIR Research Protocols
https://www.readbyqxmd.com/read/28827186/probiotics-and-antibiotic-associated-diarrhea-in-children-a-review-and-new-evidence-on-lactobacillus-rhamnosus-gg-during-and-after-antibiotic-treatment
#2
REVIEW
Cecilia Mantegazza, Paola Molinari, Enza D'Auria, Micol Sonnino, Lorenzo Morelli
Antibiotic associated diarrhea (AAD) is a common complication in childhood in the outpatient and inpatient settings. This review provides up to date information on the use of probiotics in the prevention and treatment of AAD, including that from Clostridium Difficile, in children. The most recently systematic reviews and subsequently published randomized controlleds trials are considered. Different single and multistrain probiotics are described; a specific recommendation for the use of Lactobacillus Rhamnosus GG (LGG) and Saccharomyces boulardii (Sb) emerges...
August 18, 2017: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://www.readbyqxmd.com/read/28822453/-influence-of-saccharomyces-boulardii-sachets-combined-with-bismuth-quadruple-therapy-for-initial-helicobacter-pylori-eradication
#3
X Y Zhu, J Du, J Wu, L W Zhao, X Meng, G F Liu
Objective: To evaluate the efficacy and safety of Saccharomyces boulardii Sachets combined with bismuth quadruple therapy for initial Helicobacter pylori(H.pylori) eradication. Methods: From March 2014 to March 2015, 240 participants from the third hospital of Hebei medical university with H. pylori infection were recruited and randomized into three groups: Quadruple therapy group received bismuth potassium citrate 220 mg bid + Rabeprazole 10 mg bid + amoxicillin 1 000 mg bid+ furazolidone 100 mg bid for 10 days...
August 8, 2017: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://www.readbyqxmd.com/read/28797834/antibiotic-susceptibility-of-probiotic-strains-is-it-reasonable-to-combine-probiotics-with-antibiotics
#4
C Neut, S Mahieux, L J Dubreuil
OBJECTIVE: The main goal of this study was to determine the in vitro susceptibility of strains collected from marketed probiotics to antibiotics used to treat community-acquired infections. METHODS: The minimum inhibitory concentrations (MICs) of 16 antibiotics were determined using a gradient strip (E test) or the agar dilution method for fidaxomicin. RESULTS: The probiotics demonstrated various antibiotic patterns. Bacterial probiotics are generally susceptible to most prescribed antibiotics orally administered, whereas yeast probiotics, such as Saccharomyces boulardii, are resistant...
August 7, 2017: Médecine et Maladies Infectieuses
https://www.readbyqxmd.com/read/28794958/saccharomyces-cerevisiae-var-boulardii-fungemia-following-probiotic-treatment
#5
Marcelo C Appel-da-Silva, Gabriel A Narvaez, Leandro R R Perez, Laura Drehmer, Jairo Lewgoy
Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous catheter during treatment of antibiotic-associated pseudomembranous colitis with the probiotic Saccharomyces cerevisiae var. boulardii. Fungemia was resolved after interruption of probiotic administration without the need to replace the central venous line...
December 2017: Medical Mycology Case Reports
https://www.readbyqxmd.com/read/28732069/saccharomyces-boulardii-cncm-i-745-supplementation-reduces-gastrointestinal-dysfunction-in-an-animal-model-of-ibs
#6
Paola Brun, Melania Scarpa, Chiara Marchiori, Gloria Sarasin, Valentina Caputi, Andrea Porzionato, Maria Cecilia Giron, Giorgio Palù, Ignazio Castagliuolo
BACKGROUND: We evaluated the effect of Saccharomyces boulardii CNCM I-745 on intestinal neuromuscular anomalies in an IBS-type mouse model of gastrointestinal motor dysfunctions elicited by Herpes Simplex Virus type 1 (HSV-1) exposure. METHODS: Mice were inoculated intranasally with HSV-1 (102 PFU) or vehicle at time 0 and 4 weeks later by the intragastric (IG) route (108 PFU). Six weeks after IG inoculum, mice were randomly allocated to receive oral gavage with either S...
2017: PloS One
https://www.readbyqxmd.com/read/28681177/efficacy-and-safety-of-probiotic-supplemented-triple-therapy-for-eradication-of-helicobacter-pylori-in-children-a-systematic-review-and-network-meta-analysis
#7
REVIEW
Jue-Rong Feng, Fan Wang, Xiao Qiu, Lynne V McFarland, Peng-Fei Chen, Rui Zhou, Jing Liu, Qiu Zhao, Jin Li
AIM: The aim of this study was to identify the best probiotic supplementation in triple therapy for pediatric population with Helicobacter pylori infection. METHODS: Eligible trials were identified by comprehensive searches. Relative risks with 95% confidence intervals and relative ranks with P scores were assessed. RESULTS: Twenty-nine trials (3122 participants) involving 17 probiotic regimens were identified. Compared with placebo, probiotic-supplemented triple therapy significantly increased H...
July 5, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28676009/aging-eye-microbiota-in-dry-eye-syndrome-in-patients-treated-with-enterococcus-faecium-and-saccharomyces-boulardii
#8
Giuseppe Chisari, Eleonora Margherita Chisari, Antonio Maria Borzì, Erdogan Ozyalcin, Clara Grazia Chisari
Aging seem to have a key role in the onset and progression of ocular surface diseases. Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface in which symptoms may interfere with the ability to work and carry out daily functions. METHODS: This clinical trial was a pilot study to evaluate the effects of supplementation with mixture (MYA796 and Enterococcus faecium SGEf01) on the tear film. Following the run-in period subjects were randomized in two groups: group A (n...
July 4, 2017: Current Clinical Pharmacology
https://www.readbyqxmd.com/read/28662205/correction-saccharomyces-boulardii-and-bacillus-subtilis-b10-modulate-tlrs-and-cytokines-expression-patterns-in-jejunum-and-ileum-of-broilers
#9
Imran Rashid Rajput, Huang Ying, Sun Yajing, Muhammad Asif Arain, Li Weifen, Li Ping, Dost Muhammad Bloch, Liu Wenhua
[This corrects the article DOI: 10.1371/journal.pone.0173917.].
2017: PloS One
https://www.readbyqxmd.com/read/28643294/-saccharomyces-boulardii-cncm-i-745-influences-the-gut-associated-immune-system
#10
Heike Stier, Stephan C Bischoff
BACKGROUND: The impact of the intestinal microbiome is increasing steadily with regard to the immune function und the defense against pathogens. The medicinal yeast Saccharomyces boulardii CNCM I-745 (S. boulardii) has been used as probiotic for the prevention and treatment of infectious diarrhea since more than 50 years. Meta-analyses confirm the clinical efficacy of S. boulardii to treat diarrhea of various origins in children and adults. METHOD: This review article summarizes experimental studies on molecular and immunological mechanisms which explain the proven clinical efficacy of S...
June 2017: MMW Fortschritte der Medizin
https://www.readbyqxmd.com/read/28606326/evaluation-of-the-transcription-of-interleukin-12-in-the-intestinal-mucosa-of-mice-subjected-to-experimental-toxocariasis-and-supplemented-with-saccharomyces-boulardii
#11
Micaele Quintana de Moura, Wesley Douglas da Silva Terto, Sabrina Taiza Jeske, Leonardo Mortagua de Castro, Natália Berne Pinto, Luciana Farias da Costa Avila, Fabio Pereira Leivas Leite, Maria Elisabeth Aires Berne
No abstract text is available yet for this article.
August 15, 2017: Veterinary Parasitology
https://www.readbyqxmd.com/read/28592037/-a-prospective-control-study-of-saccharomyces-boulardii-in-prevention-of-antibiotic-associated-diarrhea-in-the-older-inpatients
#12
RANDOMIZED CONTROLLED TRIAL
D M Zhang, B B Xu, L Yu, L F Zheng, L P Chen, W Wang
Objective: To study the value of Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in older inpatients. Methods: A total of 163 older patients who were treated with wide-spectrum antibiotics at least three days during January 2014 to December 2015 were randomly divided into control and study group. In study group, 81 patients were administrated with oral Saccharomyces boulardii 500 mg twice a day for 21 days. The control group was of no intervention. Morbidity rate of antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea, frequency and duration of diarrhea were recorded...
June 1, 2017: Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]
https://www.readbyqxmd.com/read/28587329/mosapride-combined-with-probiotics-on-gastrointestinal-function-and-growth-in-premature-infants
#13
Ai-Mei Zhang, Zhi-Qun Sun, Li-Ming Zhang
The aim of this study was to investigate the effects of mosapride combined with probiotics on gastrointestinal function and growth and development in premature infants. A total of 240 premature infants treated at Weifang People's Hospital between June 2012 and May 2015 who matched our criteria were randomly divided into three groups of 80 cases each. Group A received routine treatment, group B received routine treatment combined with live B. subtilis and E. faecium granules with multivitamins (Medilac-Vita), and group C received routine treatment and Saccharomyces boulardii sachets (Bioflor)...
June 2017: Experimental and Therapeutic Medicine
https://www.readbyqxmd.com/read/28572951/value-added-probiotic-development-by-high-solid-fermentation-of-sweet-potato-with-saccharomyces-boulardii
#14
Carmen Campbell, Ananda K Nanjundaswamy, Victor Njiti, Qun Xia, Franklin Chukwuma
Controlled fermentation of Sweet potato (Ipomoea batatas) var. Beauregard by yeast, Saccharomyces boulardii (MAY 796) to enhance the nutritional value of sweet potato was investigated. An average 8.00 × 10(10) Colony Forming Units (CFU)/g of viable cells were obtained over 5-day high-solid fermentation. Yeast cell viability did not change significantly over time at 4°C whereas the number of viable yeast cells reduced significantly at room temperature (25°C), which was approximately 40% in 12 months. Overall, the controlled fermentation of sweet potato by MAY 796 enhanced protein, crude fiber, neutral detergent fiber, acid detergent fiber, amino acid, and fatty acid levels...
May 2017: Food Science & Nutrition
https://www.readbyqxmd.com/read/28552806/effects-of-anti-helicobacter-pylori-concomitant-therapy-and-probiotic-supplementation-on-the-throat-and-gut-microbiota-in-humans
#15
Zi-Juan Wang, Xiao-Feng Chen, Zi-Xiao Zhang, Yu-Chen Li, Juan Deng, Jing Tu, Zhi-Qiang Song, Qing-Hua Zou
The microbiota within humans maintains homeostasis and plays important roles in human health. However, some situations such as the use of antibiotics may disrupt the microbiota balance and result in a series of adverse effects. This study aimed to investigate the effects of a commonly used anti-Helicobacter pylori concomitant therapy on the composition of the gut and throat microbiota and any antibiotic resistance that may develop. In addition to the standard regimen, two different supplementary probiotic regimens that both used Saccharomyces boulardii were included...
May 25, 2017: Microbial Pathogenesis
https://www.readbyqxmd.com/read/28552432/probiotics-in-helicobacter%C3%A2-pylori-eradication-therapy-systematic-review-and-network-meta-analysis
#16
Fan Wang, Juerong Feng, Pengfei Chen, Xiaoping Liu, Minxing Ma, Rui Zhou, Ying Chang, Jing Liu, Jin Li, Qiu Zhao
BACKGROUND: Several probiotics were effective in the eradication treatment for Helicobacter pylori (Hp), but their comparative efficacy was unknown. AIM: To compare the efficacy of different probiotics when supplemented in Hp eradication therapy. METHODS: A comprehensive search was conducted to identify all relevant studies in multiple databases and previous meta-analyses. Bayesian network meta-analysis was performed to combine direct and indirect evidence and estimate the relative effects...
September 2017: Clinics and Research in Hepatology and Gastroenterology
https://www.readbyqxmd.com/read/28482385/-a-multicenter-randomized-controlled-study-of-saccharomyces-boulardii-in-the-prevention-of-antibiotic-associated-diarrhea-in-infants-and-young-children
#17
RANDOMIZED CONTROLLED TRIAL
C M Wan, H Yu, G Liu, H M Xu, Z Q Mao, Y Xu, Y Jin, R P Luo, W J Wang, F Fang
Objective: To evaluate the efficacy and safety of Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea (AAD) in infants and young children. Method: From November 2012 to September 2013, ten research units of large teaching hospitals or children's hospitals participated in this multicenter randomized controlled clinical trial. Hospitalized young children aged between 1 month and 3 years (nongastrointestinal infection and antibiotic therapy required)were involved in our study. The children were randomly divided into control group and prevention group by means of block random allocation method...
May 4, 2017: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics
https://www.readbyqxmd.com/read/28465509/saccharomyces-boulardii-administration-changes-gut-microbiota-and-attenuates-d-galactosamine-induced-liver-injury
#18
Lei Yu, Xue-Ke Zhao, Ming-Liang Cheng, Guo-Zhen Yang, Bi Wang, Hua-Juan Liu, Ya-Xin Hu, Li-Li Zhu, Shuai Zhang, Zi-Wen Xiao, Yong-Mei Liu, Bao-Fang Zhang, Mao Mu
Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed to investigate the protective effects of S. boulardii on D-Galactosamine-induced liver injury in mice. Liver function test and histopathological analysis both suggested that the liver injury can be effectively attenuated by S. boulardii administration. In the meantime, S...
May 2, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28388647/impact-of-probiotic-saccharomyces-boulardii-on-the-gut-microbiome-composition-in-hiv-treated-patients-a-double-blind-randomised-placebo-controlled-trial
#19
RANDOMIZED CONTROLLED TRIAL
Judit Villar-García, Robert Güerri-Fernández, Andrés Moya, Alicia González, Juan J Hernández, Elisabet Lerma, Ana Guelar, Luisa Sorli, Juan P Horcajada, Alejandro Artacho, Giuseppe D Auria, Hernando Knobel
Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immunologic non-response to antiretroviral therapy (<270 CD4+Tcells/μL despite long-term suppressed viral load)...
2017: PloS One
https://www.readbyqxmd.com/read/28368269/probiotics-for-promoting-feed-tolerance-in-very-low-birth-weight-neonates-a-randomized-controlled-trial
#20
RANDOMIZED CONTROLLED TRIAL
A Shashidhar, P N Suman Rao, Saudamini Nesargi, Swarnarekha Bhat, B S Chandrakala
OBJECTIVE: To measure the efficacy of a probiotic formulation on time to reach full enteral feeds in VLBW (very low birth weight) newborns. DESIGN: Blinded randomized control trial. SETTING: A tertiary care neonatal intensive care unit (NICU) in Southern India between August 2012 to November 2013. PARTICIPANTS: 104 newborns with a birth weight of 750-1499 g on enteral feeds. INTERVENTION: Probiotic group (n=52) received a multicomponent probiotic formulation of Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium longum and Saccharomyces boulardii once a day at a dose of 1...
May 15, 2017: Indian Pediatrics
keyword
keyword
67197
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"